UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?

The Journal of pathology, 2013-08, Vol.230 (4), p.350-355

2013

Volltextzugriff (PDF)

The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases

Journal of cellular physiology, 2008-06, Vol.215 (3), p.593-602

2008

Volltextzugriff (PDF)

High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1272-1283

2014

Volltextzugriff (PDF)

MicroRNAs associated with metastatic prostate cancer

PloS one, 2011-09, Vol.6 (9), p.e24950-e24950

2011

Volltextzugriff (PDF)

Elevated expression of the centromere protein‐A(CENP‐A)‐encoding gene as a prognostic and predictive biomarker in human cancers

International journal of cancer, 2016-08, Vol.139 (4), p.899-907

2016

Volltextzugriff (PDF)

Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy

Clinical cancer research, 2010-03, Vol.16 (5), p.1442-1451

2010

Volltextzugriff (PDF)

Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer

European urology, 2018-06, Vol.73 (6), p.949-960

2018

Volltextzugriff (PDF)

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer

Cancer medicine (Malden, MA), 2018-07, Vol.7 (7), p.3385-3392

2018

Volltextzugriff (PDF)

Next generation patient-derived prostate cancer xenograft models

Asian journal of andrology, 2014-05, Vol.16 (3), p.407-412

2014

Volltextzugriff (PDF)

GATA2 as a potential metastasis-driving gene in prostate cancer

Oncotarget, 2014-01, Vol.5 (2), p.451-461

2014

Volltextzugriff (PDF)

BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells

PloS one, 2013-02, Vol.8 (2), p.e55837

2013

Volltextzugriff (PDF)

Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts

Frontiers in genetics, 2018-07, Vol.9, p.232-232

2018

Volltextzugriff (PDF)

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers

PloS one, 2011-07, Vol.6 (7), p.e21121

2011

Volltextzugriff (PDF)

Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells

Frontiers in cellular and infection microbiology, 2019-02, Vol.9, p.25-25

2019

Volltextzugriff (PDF)

The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities

Antioxidants & redox signaling, 2013-02, Vol.18 (5), p.522

2013

Volltextzugriff (PDF)

Lessons from patient-derived xenografts for better in vitro modeling of human cancer

Advanced drug delivery reviews, 2014-12, Vol.79-80, p.222-237

2014

Volltextzugriff (PDF)

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

Oncotarget, 2017-04, Vol.8 (16), p.25928-25941

2017

Volltextzugriff (PDF)

Prostate cancer metastasis-driving genes： hurdles and potential approaches in their identification

Asian journal of andrology, 2014-07, Vol.16 (4), p.545-548

2014

Volltextzugriff (PDF)

Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes

Clinical cancer research, 2006-07, Vol.12 (13), p.4043-4054

2006

Volltextzugriff (PDF)

The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer

Clinical cancer research, 2016-06, Vol.22 (11), p.2721-2733

2016

Volltextzugriff (PDF)

Epithelial immune cell-like transition (EIT): A proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers

Differentiation (London), 2012-06, Vol.83 (5), p.293-298

2012

Volltextzugriff (PDF)

Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy

The Prostate, 2007-02, Vol.67 (2), p.162-171

2007

Volltextzugriff (PDF)

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line

Laboratory investigation, 2005-11, Vol.85 (11), p.1392-1404

2005

Volltextzugriff (PDF)

Patient-Derived Xenograft Models of Human Cancer

1, 2017

Volltextzugriff (PDF)

Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10), p.2691-2704

2018

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(111)
Buchkapitel
(15)
Bücher
(1)

Sprache

Englisch
(127)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(86)
Animals
(63)
Humans
(57)
Oncology
(49)
Male
(43)
Biological And Medical Sciences
(30)
Rats
(29)
Mice
(26)
Endocrinology & Metabolism
(21)
Cell Line, Tumor
(20)
Medical Sciences
(19)
Prostatic Neoplasms - Pathology
(17)
Prostate Cancer
(16)
Female
(15)
Cell Division - Drug Effects
(14)
Xenograft Model Antitumor Assays
(14)
Cell Biology
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Gene Expression
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?

The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases

High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

MicroRNAs associated with metastatic prostate cancer

Elevated expression of the centromere protein‐A(CENP‐A)‐encoding gene as a prognostic and predictive biomarker in human cancers

Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy

Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer

Next generation patient-derived prostate cancer xenograft models

GATA2 as a potential metastasis-driving gene in prostate cancer

BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells

Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers

Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells

The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities

Lessons from patient-derived xenografts for better in vitro modeling of human cancer

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

Prostate cancer metastasis-driving genes： hurdles and potential approaches in their identification

Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes

The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer

Epithelial immune cell-like transition (EIT): A proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers

Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line

Patient-Derived Xenograft Models of Human Cancer

Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer

Suchergebnisse filtern